PRSS1 and pancreatic ductal adenocarcinoma: Pathogenic mutations in PRSS1 are associated with an over 80% chance of recurrent acute and/or chronic pancreatitis, as well as an exceptionally high lifetime risk of pancreatic ductal adenocarcinoma (estimated at 40%).